Metabolic memory underlying minimal residual disease in breast cancer
Abstract Tumor relapse from treatment‐resistant cells (minimal residual disease, MRD) underlies most breast cancer‐related deaths. Yet, the molecular characteristics defining their malignancy have largely remained elusive. Here, we integrated multi‐omics data from a tractable organoid system with a...
Enregistré dans:
Auteurs principaux: | Ksenija Radic Shechter, Eleni Kafkia, Katharina Zirngibl, Sylwia Gawrzak, Ashna Alladin, Daniel Machado, Christian Lüchtenborg, Daniel C Sévin, Britta Brügger, Kiran R Patil, Martin Jechlinger |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c0276c0d71bf4b688df33f54bc4ee1f4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS
par: Hannah K. Hopkins, et autres
Publié: (2021) -
Mutación del gen BRAF en pacientes con cánceres de colon y recto con KRAS no mutado
par: Roa,Iván, et autres
Publié: (2014) -
Current Status of Breast Organoid Models
par: Srivarshini Cherukupalli Mohan, et autres
Publié: (2021) -
Oncogene
Publié: (1987) -
Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy
par: Jin Won Kim, et autres
Publié: (2021)